EVOKE PHARMA, INC. Form SCHEDULE 13G: Beneficial ownership report (passive)
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-12-05: Form SCHEDULE 13G/A; Description Beneficial ownership report (passive); Document xslSCHEDULE_13G_X01/primary_doc.xml.
- 2025-09-08: Form SCHEDULE 13G; Description Beneficial ownership report (passive); Document xslSCHEDULE_13G_X01/primary_doc.xml.
- 2025-05-15: Form SCHEDULE 13G/A; Description Beneficial ownership report (passive); Document xslSCHEDULE_13G_X01/primary_doc.xml.
- 2025-03-24: Form SCHEDULE 13G/A; Description Beneficial ownership report (passive); Document xslSCHEDULE_13G_X01/primary_doc.xml.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-12-05 | SCHEDULE 13G/A | Beneficial ownership report (passive) | xslSCHEDULE_13G_X01/primary_doc.xml | |
| 2025-09-08 | SCHEDULE 13G | Beneficial ownership report (passive) | xslSCHEDULE_13G_X01/primary_doc.xml | |
| 2025-05-15 | SCHEDULE 13G/A | Beneficial ownership report (passive) | xslSCHEDULE_13G_X01/primary_doc.xml | |
| 2025-03-24 | SCHEDULE 13G/A | Beneficial ownership report (passive) | xslSCHEDULE_13G_X01/primary_doc.xml | |
| 2025-03-21 | SCHEDULE 13G/A | Beneficial ownership report (passive) | xslSCHEDULE_13G_X01/primary_doc.xml |